Literature DB >> 8980393

The cytotoxic action of four ammine/amine platinum(IV) dicarboxylates: a flow cytometric study.

M G Ormerod1, R M Orr, C F O'Neill, T Chwalinski, J C Titley, L R Kelland, K R Harrap.   

Abstract

We have used flow cytometry to study the mechanism of cytotoxic action of a series of ammine/amine Pt(IV) dicarboxylates [ammine diacetatodichloro(cyclohexylamine) platinum(IV), JM216; ammine dibutyratodichloro(cyclohexylamine)platinum(IV), JM221; ammine diacetatodichloro(propylamine)platinum(IV), JM223; ammine dibenzoatodichloro(propylamine)platinum(IV), JM244]. JM216 has been shown to have clinical potential and has recently entered phase II trials. All the compounds caused a slowdown in S-phase transit followed by a block in G2. Cells died either through apoptosis (largely during S-phase) or by failing to overcome the G2 block (some days after treatment). In G2, the cells either divided or enlarged and died. At equitoxic doses, JM216 showed the most apoptotic cells and had the most platinum bound to the DNA; JM244 showed the fewest apoptotic cells and had the least platinum bound to DNA. We suggest that whether apoptosis was triggered or not was governed by the total amount of Pt bound to the DNA; the type of lesion was more important in determining whether a cell became blocked in G2.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8980393      PMCID: PMC2074815          DOI: 10.1038/bjc.1996.656

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  27 in total

1.  Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia.

Authors:  M A Barry; C A Behnke; A Eastman
Journal:  Biochem Pharmacol       Date:  1990-11-15       Impact factor: 5.858

2.  DNA binding of iproplatin and its divalent metabolite cis-dichloro-bis-isopropylamine platinum (II).

Authors:  L Pendyala; A V Arakali; P Sansone; J W Cowens; P J Creaven
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

3.  Flow cytometric analysis of the kinetic effects of cisplatin on lung cancer cells.

Authors:  T Fujikane; T Shimizu; T Tsuji; S Ishida; Y Ohsaki; S Onodera
Journal:  Cytometry       Date:  1989-11

4.  BrdU-Hoechst flow cytometry: a unique tool for quantitative cell cycle analysis.

Authors:  P S Rabinovitch; M Kubbies; Y C Chen; D Schindler; H Hoehn
Journal:  Exp Cell Res       Date:  1988-02       Impact factor: 3.905

5.  Randomized trial in advanced ovarian cancer comparing cisplatin and carboplatin.

Authors:  C Mangioni; G Bolis; S Pecorelli; K Bragman; A Epis; G Favalli; A Gambino; F Landoni; M Presti; W Torri
Journal:  J Natl Cancer Inst       Date:  1989-10-04       Impact factor: 13.506

6.  Analysis of events associated with cell cycle arrest at G2 phase and cell death induced by cisplatin.

Authors:  C M Sorenson; M A Barry; A Eastman
Journal:  J Natl Cancer Inst       Date:  1990-05-02       Impact factor: 13.506

7.  A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry.

Authors:  I Nicoletti; G Migliorati; M C Pagliacci; F Grignani; C Riccardi
Journal:  J Immunol Methods       Date:  1991-06-03       Impact factor: 2.303

8.  Cisplatin/carboplatin cross-resistance in ovarian cancer.

Authors:  M E Gore; I Fryatt; E Wiltshaw; T Dawson; B A Robinson; A H Calvert
Journal:  Br J Cancer       Date:  1989-11       Impact factor: 7.640

Review 9.  Drug-target interactions: only the first step in the commitment to a programmed cell death?

Authors:  C Dive; J A Hickman
Journal:  Br J Cancer       Date:  1991-07       Impact factor: 7.640

10.  Intracellular metabolism of the orally active platinum drug JM216: influence of glutathione levels.

Authors:  F I Raynaud; D E Odell; L R Kelland
Journal:  Br J Cancer       Date:  1996-08       Impact factor: 7.640

View more
  1 in total

1.  Anti-Candida activity of a new platinum derivative.

Authors:  T Watanabe; M Takano; A Ogasawara; T Mikami; T Kobayashi; M Watabe; T Matsumoto
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.